Financing ·
Celularity Inc. entered into a $1,000,000 secured loan agreement with the Philip & Daniele Barach Family Trust on June…
CELUCelularity Inc
Celularity Inc. entered into a $1,000,000 secured loan agreement with the Philip & Daniele Barach Family Trust on June 29, 2026, bearing 4.0% interest per annum, which increases to 18.0% upon default. The loan is secured by a first-priority security interest in substantially all of the Company's personal property and matures upon receipt of gross proceeds from certain financing or strategic transactions. Additionally, Vincent LeVien resigned from the Board of Directors effective June 26, 2026. Celularity Inc. is a biotechnology company focused on developing cell therapy products.